Rani Therapeutics Holdings, Inc.

NASDAQ:RANI

Biotechnology

Healthcare
$0.80 -5.22%

-$0.04 today

Market cap
$52.19M
Beta
0.76
P/E (TTM)
-4.6
EPS (TTM)
-$0.16
52W Low $0.39High $3.87

Volume 0.23M

Average 1.15M

Income Statement

Follow revenue through to earnings.

Revenue

$1.63M

FY 2025 · Annual

+58.9% YoY

Operating Income

-$38.31M

FY 2025 · Annual

Net Income

-$29.67M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2.72M001.03M1.63M
Cost of Revenue00822K0900K
Gross Profit2.72M0(822K)1.03M733K
Gross Margin100.0%——100.0%44.9%
Research & Development26.48M36.61M39.62M26.68M20.21M
Selling, General & Admin27.83M26.84M26.48M23.95M19.74M
Operating Expenses54.32M63.45M65.28M54.34M39.04M
Depreciation & Amortization497K548K822K1.03M900K
EBITDA(52.08M)(61.66M)(61.98M)(50.52M)(37.16M)
EBITDA Margin-1917.0%——-4914.7%-2275.5%
Operating Income(51.6M)(63.45M)(66.1M)(53.31M)(38.31M)
Operating Margin-1899.1%——-5186.2%-2346.0%
Interest Income89K1.25M3.3M1.76M827K
Interest Expense466K1.07M5.09M5.03M2.89M
Other Income / Expenses(1.45M)177K(1.78M)23.3M(2.64M)
Income Before Tax(53.05M)(63.27M)(67.88M)(30.02M)(40.95M)
Pre-Tax Margin-1952.4%——-2920.0%-2507.7%
Income Tax Expense41K70K026.57M0
Net Income(8.33M)(30.59M)(33.97M)(30.02M)(29.67M)
Net Margin-306.6%——-2920.0%-1817.1%
EPS (Basic)(0.42)(1.28)(1.33)(1.05)(0.45)
EPS (Diluted)(0.42)(1.28)(1.33)(1.05)(0.45)
Weighted Avg Shares19.53M23.82M25.51M28.48M66.14M
Weighted Avg Shares (Diluted)19.53M23.82M25.51M28.48M66.14M

RANI Earnings Waterfall · TTM

NASDAQ:RANI · Revenue to Net Income

Key Ratios

EPS$-0.41
Gross Margin47.6%
Net Margin-279.3%
P/E Ratio-2.8
P/S Ratio53.3

Analysis

$3.2M of revenue converted into -$29.4M of net income for the selected period. Gross margin is 47.6% and net margin is -279.3%, showing how much revenue survives after costs and taxes. EPS is $-0.41, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipSep 29, 2026
4Statement of changes in beneficial ownershipSep 29, 2026
SC 13G/ASC 13G/A filingAug 14, 2026
10-QQuarterly reportAug 13, 2026
8-KCurrent reportAug 13, 2026

How much revenue does RANI generate?

Rani Therapeutics Holdings, Inc. (RANI) reported $1.63M of revenue in fiscal 2025.

Is RANI profitable?

Rani Therapeutics Holdings, Inc. (RANI) reported -$29.67M of net income, with a net margin of -1817.1%.